Takashi Takeda
Keio University
26 Papers
26 Citations
Takashi Takeda is an academic researcher from Keio University. The author has contributed to research in topics: Cancer & Endometrial cancer. The author has an hindex of 8, co-authored 20 publications.
Chat about Author
Papers
ARID1A gene mutation in ovarian and endometrial cancers (Review)
Takashi Takeda,Kouji Banno,Ryuichiro Okawa,Megumi Yanokura,Moito Iijima,Haruko Kunitomi,Kanako Nakamura,Miho Iida,Masataka Adachi,Kiyoko Umene,Yuya Nogami,Kenta Masuda,Yusuke Kobayashi,Eiichiro Tominaga,Daisuke Aoki +14 more
TL;DR: Development of a screening method that can detect mutations of ARID1A and activation of the PI3K/AKT pathway might enable early diagnosis of endometriosis-associated ovarian cancers and endometrial cancers.
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Yusuke Kobayashi,Hiroyasu Kashima,Yohan Suryo Rahmanto,Kouji Banno,Yu Yu,Yu Yu,Yusuke Matoba,Keiko Watanabe,Moito Iijima,Takashi Takeda,Haruko Kunitomi,Miho Iida,Masataka Adachi,Kanako Nakamura,Kosuke Tsuji,Kenta Masuda,Hiroyuki Nomura,Eiichiro Tominaga,Daisuke Aoki +18 more
TL;DR: Inhibition at any point in the mevalonate pathway, and especially of farnesyl pyroph phosphate and geranylgeranyl pyrophosphate, suppresses growth of ovarian cancer cells, and the mechanism of the antitumor effect from a metabolic perspective is investigated.
New use of microsatellite instability analysis in endometrial cancer
Haruko Kunitomi,Kouji Banno,Megumi Yanokura,Takashi Takeda,Moito Iijima,Kanako Nakamura,Miho Iida,Masataka Adachi,Keiko Watanabe,Yusuke Matoba,Yusuke Kobayashi,Eiichiro Tominaga,Daisuke Aoki +12 more
TL;DR: The use of MSI analysis as a predictive biomarker for the therapeutic efficacy of these drugs may be useful for reducing the costs of drug therapy.
Genome-wide analysis of gynecologic cancer: The cancer genome atlas in ovarian and endometrial cancer (Review)
Moito Iijima,Kouji Banno,Ryuichiro Okawa,Megumi Yanokura,Miho Iida,Takashi Takeda,Haruko Kunitomi-Irie,Masataka Adachi,Kanako Nakamura,Kiyoko Umene,Yuya Nogami,Kenta Masuda,Eiichiro Tominaga,Daisuke Aoki +13 more
TL;DR: Important results have been revealed by genome-wide analyses; however, the pathogenic underlying mechanisms of gynecologic cancer will require further studies and multilateral evaluation using epigenetic, transcriptomic and proteomic analyses, in addition to genomic analysis.
Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach
Yusuke Kobayashi,Kouji Banno,Haruko Kunitomi,Shimpei Nagai,Takayuki Takahashi,Mayuka Anko,Moito Iijima,Takashi Takeda,Yusuke Matoba,Kanako Nakamura,Kosuke Tsuji,Eiichiro Tominaga,Daisuke Aoki +12 more
TL;DR: There is an urgent need for researchers to be actively involved in investigator-initiated clinical trials because it is becoming increasingly clear that statins can be effective in the prevention of coronary disease, heart failure, and arrhythmia.
14